bims-mihora Biomed News
on Mitohormesis, repair and aging
Issue of 2026–03–15
33 papers selected by
Lisa Patel, Istesso



  1. Front Immunol. 2026 ;17 1747401
      The integrated stress response (ISR) is a conserved cyto-protective mechanism, which has fundamental roles in maintaining cell viability under various conditions when intracellular and/or extracellular homeostasis is disrupted. ISR features phosphorylation of the alpha subunit of eukaryotic translation initiation factor 2 (eIF2α), leading to a global reduction in protein synthesis. Emerging evidence suggests that activation of ISR may have anti-inflammatory effects. In this concise review, we summarize the current experimental evidence in this regard from both in vitro and in vivo studies. It is suggested that ISR may represent a potential drug target for developing novel anti-inflammatory therapies.
    Keywords:  ATF4; GADD34; anti-inflammation; eIF2a; inflammatory disease; integrated stress response; phosphorylation; protein translation
    DOI:  https://doi.org/10.3389/fimmu.2026.1747401
  2. BMB Rep. 2026 Mar 09. pii: 6743. [Epub ahead of print]
      Cellular senescence is an irreversible program of cell-cycle arrest that accumulates with age, contributing to chronic inflammation and various age-related diseases. A key feature of senescence paradigms is mitochondrial dysfunction, which involves not just a single defect but a series of coordinated changes in bioenergetics, redox homeostasis, mitochondrial quality control, and organelle interaction. Senescent cells often display a "quantity-quality imbalance" in their mitochondria: while the mitochondrial mass may increase, their efficiency in oxidative phosphorylation decreases, leading to a destabilized membrane potential (ΔΨm) and elevated levels of mitochondrial reactive oxygen species (mtROS). These interrelated changes can exacerbate senescence through persistent stress signaling, impaired turnover of damaged mitochondrial components, and alterations in organelle contacts, such as those between endoplasmic reticulum (ER) and mitochondria, and between mitochondria and lysosomes. Given that these phenotypes differ depending on cell type, triggering factors, and timing, no single assay can adequately define senescence-associated mitochondrial dysfunction. In this review, we present practical, complementary strategies that include extracellular flux-based respiration profiling, ATP output measurement, ΔΨm and ROS assessments, flux-based mitophagy reporters, quantitative network imaging, and contact-site assays. We propose minimal assay bundles that allow for a thorough multidimensional analysis. By establishing standardized, orthogonal measures of mitochondrial quantity and quality, we aim to enhance mechanistic understanding and facilitate the rational evaluation of mitochondria-targeted senolytic and senomorphic therapies.
  3. Mech Ageing Dev. 2026 Mar 05. pii: S0047-6374(26)00019-9. [Epub ahead of print]231 112167
      Mitochondria are central to cellular energy metabolism, redox balance, and signaling, and their integrity is maintained by a multilayered mitochondrial quality control (MQC) system. This system includes proteostasis, dynamics, biogenesis, and mitophagy, which together repair or remove damaged organelles. Mitochondria-derived vesicles (MDVs) have emerged as an additional MQC component. MDVs are small vesicles that bud from mitochondria and selectively transport damaged mitochondrial proteins, lipids, and nucleic acids to endolysosomal compartments or other intracellular destinations, enabling rapid and localized responses to mitochondrial stress. Acting upstream of or in parallel with mitophagy, MDVs can avoid or delay irreversible mitochondrial damage and help preserve cellular homeostasis. Aging and age-associated disorders are characterized by progressive mitochondrial dysfunction and chronic inflammation. Age-related changes in intracellular trafficking, lysosomal function, and vesicle dynamics may impair MDV formation, cargo selection, and targeting. Under conditions of defective degradation, mitochondrial components may also appear in extracellular vesicles, potentially contributing to altered intercellular signaling and inflammation. In the nervous system, where energetic demands are high and mitochondrial turnover requires tight regulation, such alterations may be especially harmful. This review summarizes MQC mechanisms in neurons, with a focus on MDVs, their dysregulation during aging and neurodegeneration, and implications for biomarkers and therapeutic strategies.
    Keywords:  Alzheimer’s disease; Huntington’s disease; Parkinson’s disease; Tau protein, α-synuclein
    DOI:  https://doi.org/10.1016/j.mad.2026.112167
  4. Exp Mol Med. 2026 Mar 13.
      Mitochondrial dysfunction is a critical driver of metabolic dysfunction-associated steatotic liver disease progression to steatohepatitis (MASH), yet the mechanisms governing mitochondrial quality control in hepatocytes remain poorly defined. Here we identify TANK-binding kinase 1 (TBK1) as an essential regulator of hepatic mitophagy and lysosomal activity. Using TBK1-deficient hepatocytes and liver-specific TBK1-knockout mice, we show that TBK1 loss leads to the accumulation of depolarized, reactive oxygen species-producing mitochondria due to impaired mitophagy flux, including defective lysosomal degradation. Mechanistically, TBK1 is required for p62 phosphorylation at Ser403 and partially modulates mTOR signaling to preserve lysosomal activity. Notably, both human samples and murine steatohepatitis models exhibited a substantial decline in TBK1 kinase activity. Therapeutic restoration of TBK1 expression via AAV8 delivery in MASH mouse model enhanced mitophagy, reduced mitochondrial burden and ameliorated liver fibrosis. Collectively, these findings establish TBK1 as a critical guardian of mitochondrial and lysosomal homeostasis in MASH.
    DOI:  https://doi.org/10.1038/s12276-026-01672-9
  5. Aging Dis. 2026 Mar 04.
      Mitochondria are increasingly recognized as central regulators of skin health and aging, providing ATP and coordinating redox signaling, mitophagy, and cell fate decisions. In cutaneous tissues, mitochondrial integrity sustains fibroblast-driven collagen synthesis, keratinocyte proliferation, melanocyte homeostasis, and efficient wound repair. With advancing age and cumulative ultraviolet exposure, mitochondria accumulate hallmark defects. Mitochondrial DNA mutations and deletions, impaired oxidative phosphorylation, excessive reactive oxygen species production, diminished mitophagy and biogenesis, disrupted fission-fusion dynamics, NAD⁺ decline, and sirtuin dysregulation all converge to undermine energy metabolism, amplify inflammatory signaling, and accelerate fibroblast senescence, extracellular matrix degradation, pigmentary changes, and delayed wound healing. Recent research also highlights weakened antioxidant defenses and extracellular vesicle-mediated propagation of mitochondrial stress across the cutaneous microenvironment, underscoring the organelle's central role in skin aging. Against this mechanistic backdrop, mitochondria-targeted interventions are emerging as promising therapeutic strategies. Extracellular vesicles loaded with NAD⁺ precursors, antioxidant enzymes, or mitophagy stimulators show preclinical efficacy in restoring bioenergetics and accelerating wound closure. Mitochondria-directed antioxidants such as melatonin and coenzyme Q10, NAD⁺ boosters and sirtuin activators, red and near-infrared photobiomodulation, and NRF2-based redox reprogramming each enhance mitochondrial homeostasis while improving collagen synthesis, pigmentation balance, and re-epithelialization. Early translational and clinical studies indicate that these approaches protect against UV-induced mitochondrial DNA damage, reduce oxidative stress, and improve cutaneous structure and function. Collectively, these findings position mitochondria as a modifiable hub for cutaneous aging and wound repair, and highlight the potential of integrated metabolic, antioxidant, and vesicle-based approaches to transform dermatologic anti-aging and wound-care interventions.
    DOI:  https://doi.org/10.14336/AD.2025.1585
  6. Biol Pharm Bull. 2026 ;49(3): 457-466
      Mitochondria are essential organelles responsible for energy production, autophagy, and apoptosis, and mitochondrial dysfunction has been implicated in various diseases affecting the heart, liver, and kidneys. Mitochondrial transplantation, wherein isolated mitochondria are administered into cells or tissues, has recently emerged as a promising therapeutic approach for restoring cellular functions by enhancing ATP generation and reducing oxidative stress. However, the characteristics and functional diversity of the mitochondria isolated from different cell types remain poorly understood. Here, we aimed to identify the optimal mitochondrial source for transplantation therapy by comparing mitochondria isolated from several mammalian cell types, including mesenchymal stromal, hepatic, muscular, and pluripotent stem cells. Mitochondria were isolated using a streptolysin O-based isolation method and characterized through particle size, zeta potential, protein content, and ATP content. The isolated mitochondria exhibited uniform morphology, negative surface charge, sufficient protein yield, and ATP content, indicating successful preparation of functionally competent organelles suitable for comparative analysis. The mitochondria derived from mesenchymal stromal cells exhibited the highest bioenergetic activity. Adding these mitochondria enhanced cellular proliferation, oxygen consumption, and resistance to oxidative stress in recipient cells. Collectively, these findings demonstrate that mitochondria isolated from autologous mesenchymal stromal cells possess superior bioenergetic properties, highlighting their potential as an optimal source for mitochondrial transplantation therapy and providing new insights into the design of mitochondria-based therapeutics.
    Keywords:  ATP production; cellular bioactivity; mesenchymal stromal cell; mitochondrial transplantation; oxidative stress
    DOI:  https://doi.org/10.1248/bpb.b25-00716
  7. Front Immunol. 2026 ;17 1692597
      Sepsis is a complex condition marked by significant dysregulation of immune and metabolic processes, leading to multi-organ failure. Macrophages, key mediators of immune activity, demonstrate functional flexibility by switching between pro- and anti-inflammatory phenotypes in response to inflammatory and metabolic signals in their local environment. During sepsis, pathogen-derived signals activate host defense responses that impair intercellular oxygen transport, increase oxygen consumption by immune cells within inflamed tissues, and promote a metabolic transition toward aerobic glycolysis. This metabolic transition supports immune defense mechanisms, and the metabolic by-products further regulate immune activation through feedback in key signaling cascades, promoting a transition toward tolerance during the resolution phase. Since mitochondria are central hubs for cellular energy homeostasis, they play a crucial role in this process. Mitochondrial dysfunction and metabolic changes are now recognized as major contributors to the progression of sepsis. The accumulation of mitochondria-derived metabolites can further modulate immune signaling pathways, actively influencing macrophage function. Therefore, this review emphasizes the crosstalk between macrophage polarization and mitochondrial changes, with a focus on new molecular insights and the potential of mitochondrial pathways as biomarkers or therapeutic targets. These concepts provide a foundation for advancing both experimental research and clinical applications, potentially guiding future interventions to better manage sepsis and its associated mortalities.
    Keywords:  crosstalk; macrophage polarization; metabolic adaptation; mitochondrial dysfunction; sepsis
    DOI:  https://doi.org/10.3389/fimmu.2026.1692597
  8. Int J Mol Sci. 2026 Mar 06. pii: 2448. [Epub ahead of print]27(5):
      Cerebral ischemia-reperfusion (I/R) injury is a major pathological contributor to neurological deterioration following ischemic stroke (IS) and remains a critical barrier to effective neuroprotection. Accumulating evidence indicates that cerebral I/R injury is driven not by isolated stress responses but by coordinated and dynamic interactions among multiple cellular pathways. Among these, the bidirectional crosstalk between mitophagy and oxidative stress has emerged as a central regulatory axis. Moderate oxidative stress can function as an adaptive signal, activating protective mitophagy through key pathways such as AMPK/ULK1 signaling and cardiolipin externalization, thereby facilitating mitochondrial quality control and maintaining cellular homeostasis. Conversely, appropriately regulated mitophagy limits excessive reactive oxygen species (ROS) production by removing dysfunctional mitochondria, forming a negative feedback mechanism. However, dysregulation or excessive activation of either process disrupts this balance, leading to a self-amplifying cycle of mitochondrial dysfunction and oxidative damage that exacerbates neuronal injury. This review systematically summarizes the molecular mechanisms governing the oxidative stress-mitophagy crosstalk in cerebral I/R injury, highlighting key signaling nodes and regulatory pathways that determine protective versus detrimental outcomes. Furthermore, we discuss emerging therapeutic strategies aimed at precisely modulating this axis in a spatiotemporal- and intensity-dependent manner. By integrating mechanistic insights with translational perspectives, this review provides a conceptual framework for developing targeted neuroprotective interventions based on coordinated regulation of mitochondrial quality control and redox homeostasis.
    Keywords:  cerebral ischemia–reperfusion injury; ischemic stroke; mitophagy; oxidative stress; signaling pathway
    DOI:  https://doi.org/10.3390/ijms27052448
  9. Neuron. 2026 Mar 11. pii: S0896-6273(26)00086-3. [Epub ahead of print]
      Amyotrophic lateral sclerosis (ALS) is genetically and clinically heterogeneous, yet convergent pathogenic mechanisms remain poorly defined. A CRISPR-Cas9 screen identified phosphoglycerate mutase-5 (PGAM5) as a common mediator of ALS pathogenesis. PGAM5 activates the mitochondrial integrated stress response (mtISR) via dephosphorylation of metallopeptidase OMA1 at Ser223 and Ser237, thereby driving neuromuscular junction disruption and motor deficits. We show that PGAM5 is a substrate of valosin-containing protein (VCP) and is consistently elevated in spinal cords from sporadic ALS patients, in human spinal cord organoids derived from sporadic or familial ALS, and in ALS mouse models. The disruption of PGAM5-OMA1 interaction by a selective inhibitor (TAT-PO1) or pharmacological inhibition of PGAM5 with telmisartan suppresses mtISR activation and ameliorates ALS-related phenotypes by reshaping mtISR outputs in a manner distinct from those elicited by activation of translation initiation factor 2B (eIF2B). These findings establish PGAM5 as a convergent and actionable therapeutic target across ALS subtypes.
    Keywords:  ALS; NMJ; PGAM5; VCP; amyotrophic lateral sclerosis; mitochondrial integrated stress response; mitochondrial phosphatase phosphoglycerate mutase 5; mtISR; neuromuscular junction; valosin-containing protein
    DOI:  https://doi.org/10.1016/j.neuron.2026.02.003
  10. Autophagy. 2026 Mar 09.
      Fibrous dysplasia (FD) is a bone mesenchymal stromal cells (BMSCs)-derived disorder caused by GNAS gene mutation, characterized by excessive fibrous tissue proliferation in bone and the formation of immature trabecular bone. Although impaired osteogenesis of BMSCs is central to FD pathogenesis, the underlying mechanism remains largely elusive. Here we demonstrate that hyperactivation of the cAMP-PRKA/PKA signaling axis disrupts mitochondrial homeostasis through impaired mitophagy, ultimately leading to diminished amorphous calcium phosphate (ACP) secretion and consequent mineralization failure in FD. Mechanistically, in FD BMSCs, PRKA activation inhibits DNM1L/DRP1 recruitment to mitochondria through phosphorylation at S637, thereby suppressing mitochondrial fission. Consequently, excessive mitochondrial fusion leads to an elevated mitochondrial membrane potential, impaired mitophagy, and diminished ACP release. Collectively, our findings reveal a novel signaling nexus linking cAMP-PRKA signaling, mitochondrial dynamics, and biomineralization processes in FD pathogenesis, providing critical insights into the molecular basis of this disorder.
    Keywords:  Amorphous calcium phosphate; biomineralization; cAMP-PRKA pathway; fibrous dysplasia; mitophagy
    DOI:  https://doi.org/10.1080/15548627.2026.2643409
  11. NPJ Aging. 2026 Mar 11.
      Stroke is one of the leading causes of mortality and disability worldwide, with ischemic stroke accounting for over 87% of all stroke cases. Chronic kidney disease (CKD) is one of the major risk factors for stroke, as CKD patients have shown evidence of impaired cerebral autoregulation leading to exacerbated stroke pathology. The worsening of stroke outcomes in CKD patients is limitedly understood. Inflammation plays a pivotal role in driving the CKD-stroke pathology. The cGAS-STING (cyclic GMP-AMP synthase-stimulator of interferon gene) pathway acts as a key mediator of inflammation in both pathologies. As mitochondrial dysfunction plays a common connecting link between stroke and CKD, activation of the innate-immune response mediated by cGAS-STING pathway becomes inevitable. Therefore, it becomes imperative to understand the role of mitochondria in the exacerbation of stroke outcomes following CKD. In addition, the critical role of altered immune response leading to exacerbated mitochondrial dysfunction and aging in CKD-stroke complex is also crucial to investigate. To study this, CKD was induced in male Sprague Dawley rats followed by middle cerebral artery occlusion (MCAo) to develop a CKD-Stroke complex animal model. Behavioral studies were conducted, and tissues were harvested for biochemical, histological, molecular, mitochondrial and genetic studies. Our findings from transcriptomic and proteomic analyses confirm upregulation of STING, interferons and related genes, alongside downregulation of mitochondrial health markers, in the CKD-stroke complex. This molecular profile reflects accelerated mitochondrial aging due to altered innate immunity mediated by cGAS-STING pathway.
    DOI:  https://doi.org/10.1038/s41514-026-00361-1
  12. Int J Mol Sci. 2026 Feb 26. pii: 2206. [Epub ahead of print]27(5):
      Aging is associated with complex physiological changes that influence drug pharmacokinetics, including alterations in mitochondrial function and gastrointestinal (GI) drug transporter activity. Mitochondrial dysfunction-characterized by reduced oxidative phosphorylation, mitochondrial DNA damage, and increased reactive oxygen species-is a hallmark of aging and may affect energy- and redox-dependent cellular processes in the gut. At the same time, aging can modulate the expression and function of key intestinal drug transporters from the ATP-binding cassette (ABC) and solute carrier (SLC) families, which play a central role in oral drug absorption and bioavailability. This review examines the molecular links between age-related mitochondrial dysfunction and regulation of GI drug transporters, with a focus on their pharmacokinetic consequences in older adults. We summarize evidence of mitochondrial decline in the aging intestine and discuss how mitochondrial signals-such as cellular energy status and oxidative stress-regulate transporter expression and activity via pathways including AMPK (AMP-Activated Protein Kinase), Sirtuin-FOXO (Forkhead box O transcription factors), Nrf2 (Nuclear factor erythroid 2-related factor 2), and NF-κB (Nuclear Factor kappa B). We highlight clinical examples of drugs showing age-related changes in bioavailability that may be attributable to transporter dysfunction. Finally, we discuss therapeutic implications for geriatric pharmacotherapy, including dose adjustment, management of transporter-mediated drug-drug interactions, and strategies aimed at preserving mitochondrial health.
    Keywords:  ABCG2; P-glycoprotein (ABCB1); aging; bioavailability; drug–drug interactions; elderly patients; energy metabolism; gastrointestinal tract; geriatric pharmacotherapy; intestinal drug absorption; mitochondrial dysfunction; oxidative stress; pharmacokinetics; polypharmacy
    DOI:  https://doi.org/10.3390/ijms27052206
  13. Crit Rev Eukaryot Gene Expr. 2026 ;36(1): 37-50
      PTEN-Induced Putative Kinase 1 (Pink1) is a key regulatory protein in mitochondrial autophagy: upon mitochondrial damage, Pink1 selectively binds to the mitochondrial outer membrane, thereby recruiting and phosphorylating Parkin. However, the mechanism by which the Pink1/Parkin signaling pathway functions in podocytes remains unclear, and this study aimed to investigate the role of this pathway in mitochondrial dysfunction associated with glomerular podocyte injury. For this purpose, flow cytometry was used to detect podocyte apoptosis rate; transmission electron microscopy was employed to observe the quantity and morphological changes of podocyte mitochondrial autophagosomes; and reverse transcription-polymerase chain reaction (RT-PCR) and western blot were performed to quantify the mRNA and protein expression levels of Pink1, Parkin, and LC3-II, respectively. The results showed that compared with the Control and Pink1 groups, the PAN group exhibited a significantly increased podocyte apoptosis rate; in the Pink1 group, mitochondria gradually became swollen and rounded, with disordered arrangement. These findings confirmed that PAN can induce podocyte injury and that this process is associated with the Pink1/Parkin pathway. In conclusion, the Pink1/Parkin signaling pathway plays a crucial role in mitochondrial dysfunction during glomerular podocyte injury, and these results provide a new perspective for the potential clinical application of the Pink1/Parkin signaling pathway in podocyte injury and future related research.
    DOI:  https://doi.org/10.1615/CritRevEukaryotGeneExpr.2026061692
  14. Cells. 2026 Mar 09. pii: 486. [Epub ahead of print]15(5):
      Global climate change has increased the frequency and intensity of heat waves, posing a significant threat to livestock production. During heat exposure, the disruption of intestinal barrier integrity is a pivotal event in the pathogenesis of heat stress-induced intestinal injury. Endoplasmic reticulum (ER) stress and mitochondrial dysfunction are key consequences of heat stress at the cellular level. However, direct causal evidence linking ER stress to mitochondrial dysfunction in heat-stressed enterocytes remains limited. To investigate this, we used an integrated transcriptomic, metabolomic, and functional validation strategy to assess mitochondrial bioenergetics and cellular ultrastructure in porcine intestinal epithelial (IPEC-J2) cells under acute heat stress. Transcriptomic analysis revealed extensive reprogramming, highlighting the significant enrichment of pathways related to protein processing in the endoplasmic reticulum, apoptosis, and MAPK signaling. Untargeted metabolomics identified significant perturbations in amino acid and energy metabolism, as well as altered bile acid profiles. Functional assessments confirmed that heat stress severely impaired mitochondrial bioenergetics, as evidenced by reduced maximal respiration and ATP production, and induced ultrastructural damage to mitochondria. The pharmacological inhibition of ER stress by 4-phenylbutyric acid (4-PBA) significantly attenuated the mitochondrial bioenergetic impairment and ultrastructural damage, whereas ER stress induction recapitulated these defects. We demonstrate that heat stress induces profound transcriptional and metabolic remodeling characterized by ER stress activation, which critically mediates subsequent mitochondrial bioenergetic dysfunction and ultrastructural damage. Our findings suggest that targeting ER stress may represent a promising therapeutic strategy to ameliorate enterocyte mitochondrial dysfunction and mitigate heat stress-induced intestinal injury in livestock.
    Keywords:  endoplasmic reticulum stress; heat stress; intestinal epithelium; mitochondrial dysfunction; multi-omics
    DOI:  https://doi.org/10.3390/cells15050486
  15. Int J Mol Sci. 2026 Feb 26. pii: 2201. [Epub ahead of print]27(5):
      Skin aging, photoaging, and chronic wounds are increasingly recognized to be driven by mitochondria-centered mechanisms characterized by oxidative stress, defective mitophagy, and impaired bioenergetics in cutaneous cells. Autologous biologics, including platelet-rich plasma, stromal vascular fraction, bone marrow aspirate concentrate, and mesenchymal stromal/stem cell-derived products, are widely used for skin rejuvenation and wound repair. Recent studies have suggested that many of these effects are mediated by mitochondrial mechanisms, including metabolic reprogramming, redox modulation, and intercellular mitochondrial transfer. Concurrently, biophysical modalities such as red/near-infrared photobiomodulation (PBM), low-intensity pulsed ultrasound, mechanical stimulation, and nanoengineered cues can modulate mitochondrial function in skin-relevant cells. In this review, we integrate these lines of evidence to introduce the concept of mitochondria-targeted biophysical priming of autologous biologics for dermatological applications. We summarize the mitochondrial biology in skin pathology, evaluate these biologics as mitochondria-active therapies, and outline ex vivo priming implementation using PBM, ultrasound, or mechanical stimulation. Finally, we discuss key regulatory considerations that support clinical translation.
    Keywords:  biophysical priming; bone marrow aspirate concentrate (BMAC); chronic wounds; low-intensity pulsed ultrasound (LIPUS); mesenchymal stromal cells (MSCs); mitochondria; photobiomodulation (PBM); platelet-rich plasma (PRP); skin aging; stromal vascular fraction (SVF)
    DOI:  https://doi.org/10.3390/ijms27052201
  16. Ann Med. 2026 Dec;58(1): 2641277
      Bone defect repair remains a significant challenge in orthopedics, particularly for critical-sized bone defects, which often result in nonunion. Traditional treatments have numerous limitations. Recent studies have highlighted the pivotal role of mitochondria as cellular energy and metabolic hubs influencing the function of osteoblasts, osteoclasts, and chondrocytes. Mitochondria regulate energy metabolism, ROS signaling, mitochondrial dynamics, and apoptosis, all of which are essential for maintaining proper bone function. Mitochondrial dysfunction has been identified as a key intrinsic factor contributing to the failure of bone repair. Thus, targeting mitochondria has emerged as a promising therapeutic strategy. This article systematically reviewed the various functional roles of mitochondria in bone repair and evaluated the current progress of mitochondrial-targeted therapeutic strategies. We focused on the mechanisms of action and preclinical advancements related to small molecule compounds, functionalized biomaterials, and advanced cell therapies, offering a theoretical foundation for their potential clinical application. Mitochondrial-targeted therapies show significant promise for enhancing bone repair by improving cellular energy metabolism, restoring redox homeostasis, optimizing mitochondrial quality control, and promoting cell survival. However, this field faces several challenges, including improving targeted delivery efficiency, ensuring long-term safety, and translating these strategies into clinical practice. Future research should prioritize the development of more precise delivery technologies, exploration of multi-target synergistic approaches, and rigorous clinical trials to support the practical application of mitochondrial-targeted therapies for clinical bone regeneration.
    Keywords:  Mitochondria; bone repair; energy metabolism; mitochondrial dynamics; reactive oxygen species; targeted therapy
    DOI:  https://doi.org/10.1080/07853890.2026.2641277
  17. Autophagy. 2026 Mar 08. 1-17
      Neuronal axon regeneration is a complex and coordinated reorganization process that requires the involvement of mitochondria. Here, we demonstrated that FUNDC1 (FUN14 domain containing 1)-mediated mitophagy played a crucial role in determining the intrinsic capacity for axonal regrowth and peripheral nerve recovery. We found that acute nerve injury resulted in the accumulation of impaired mitochondria at the axonal injury site, accompanied by an increase in the expression of the mitophagy receptor FUNDC1. Strikingly, overexpression of FUNDC1 enhanced axonal regeneration both in vitro and in vivo, likely by maintaining a healthy mitochondrial population through mitophagy. Similarly, treatment with urolithin A (UA), a natural mitophagy inducer, promoted axon regrowth after injury. Conversely, fundc1 deletion impaired regeneration, an effect reversed by reintroducing wild type (WT) FUNDC1 in neurons but not an MAP1LC3B/LC3 (microtubule associated protein 1 light chain 3 beta)-interacting region (LIR) mutant. Metabolic profiling further demonstrated that FUNDC1-mediated mitophagy drives dorsal root ganglion (DRG) neurons regeneration through enhanced carnosine biosynthesis. Mechanistically, sciatic nerve injury (SNI) in Fundc1 transgenic (TG) mice upregulated NRF1 (nuclear respiratory factor 1) and PPARGC1A/PGC-1α (PPARG coactivator 1 alpha), which stimulated mitochondrial biogenesis and activated Carns1 (carnosine synthase 1) transcription. This increased carnosine biosynthesis, aiding peripheral nerve recovery through its antioxidant effects. Our findings highlighted FUNDC1-mediated mitophagy as a key mechanism in nerve regeneration, linking mitochondrial quality control, metabolic adaptation, and nerve regeneration.Abbreviations: Δψm: mitochondrial membrane potential; DIV: days in vitro; DRG: dorsal root ganglion; KO: knockout; LIR: LC3-interacting region; P60: postnatal day 60; PNS: peripheral nervous system; PSI: post sciatic nerve injury; ROS: reactive oxygen species; SD: standard deviation; SNI: sciatic nerve injury; TEM: transmission electron microscopy; TG: transgenic; TMRE: tetramethylrhodamine ethylester; UA: urolithin A; WT: wild type.
    Keywords:  Axon regeneration; FUNDC1; NRF1; carnosine; mitochondrial quality; mitophagy
    DOI:  https://doi.org/10.1080/15548627.2026.2629721
  18. Life Med. 2026 Jan;5(1): lnag004
      The liver, the largest glandular organ in humans, exhibits a unique and robust regenerative capacity following injury. This regenerative response is orchestrated through a highly regulated network of cellular and molecular signals. Here, we review the cytokine-mediated regulation of liver regeneration, emphasizing autocrine, paracrine, as well as endocrine pathways. Hepatocyte proliferation is modulated not only by intrinsic signals but also by cytokines derived from non-parenchymal cells-including Kupffer cells, hepatic stellate cells, and liver sinusoidal endothelial cells-as well as by endocrine cues from the systemic circulation. From the perspective of metabolic reprogramming, these regulatory pathways illustrate how adaptive changes in glucose, lipid, and amino acid metabolism collectively sustain the cellular activities essential for liver regeneration. We further explore how metabolic adaptations contribute to regeneration, providing mechanistic insights and revealing potential therapeutic targets for liver diseases. Finally, we discuss emerging strategies that target cytokine networks and metabolic pathways to enhance liver regeneration, highlighting recent advances in translational applications.
    DOI:  https://doi.org/10.1093/lifemedi/lnag004
  19. Bioorg Chem. 2026 Mar 02. pii: S0045-2068(26)00244-0. [Epub ahead of print]174 109708
      Hydrogen sulfide (H₂S) plays a crucial neuroprotective role in Parkinson's disease (PD). Cystathionine-β-synthase (CBS), a key enzyme involved in H₂S biosynthesis, exhibits expression deficiencies that are closely linked to PD progression. This suggests that enhancing the CBS-H₂S signaling axis to restore H₂S homeostasis may be a critical approach for preventing and treating PD. In the present study, the H₂S donor sulforaphane (SFN) was investigated to elucidate its neuroprotective mechanisms through activation of the CBS-H₂S axis. siRNA-mediated silencing of Nrf2 and CBS was employed to clarify the role of each in SFN's effects. Our findings demonstrate that SFN promotes CBS expression and H₂S synthesis, activates mitophagy to clear damaged mitochondria, reduces mitochondrial-derived reactive oxygen species (mtROS) levels, and inhibits the activation of NLRP3 inflammasomes and caspase-1. In the MPTP-induced PD mouse model, SFN improved motor performance, increased the survival rate of tyrosine hydroxylase (TH)-positive dopaminergic neurons in the substantia nigra, and restored dopamine metabolism in the striatum, normalizing the DOPAC/DA and 5-HIAA/5-HT ratios. Electron microscopy revealed that SFN facilitated the clearance of damaged mitochondria through autophagosomes and blocked mtROS-mediated NLRP3 inflammasome activation. In the MPP+-induced BV-2 microglial cell model, SFN upregulated CBS expression, enhanced H₂S synthesis, increased the LC3-II/I ratio, and inhibited p62 degradation, thereby promoting the recovery of mitochondrial membrane potential and reducing ROS release. These effects were still observed under Nrf2 silencing conditions, indicating that SFN's neuroprotective effects are mediated through the CBS-H₂S axis independently of Nrf2 signaling. Collectively, these findings indicate that SFN reshapes the CBS-H₂S signaling axis, activates mitochondrial autophagy, and suppresses inflammation, offering novel insights into multi-target therapeutic approaches for PD and underscoring the essential role of H₂S in neuroprotection.
    Keywords:  CBS–H₂S axis; Mitophagy; NLRP3 inflammasome; Parkinson's disease; Sulforaphane
    DOI:  https://doi.org/10.1016/j.bioorg.2026.109708
  20. Arch Physiol Biochem. 2026 Mar 13. 1-22
      Critical limb ischaemia (CLI), a severe peripheral artery disease, reduces blood flow, disrupting lipid metabolism and mitochondrial function. This leads to muscle loss, impaired repair, and greater limb loss risk. Standard diagnostics emphasise imaging and perfusion, often missing metabolic changes. The LIPID-CLI framework uses high-resolution mass spectrometry to analyse lipid shifts under mitochondrial stress. Biopsy limits shifted focus to blood markers reflecting tissue lipids. Altered ceramides and phospholipids indicate lipid-mitochondrial dysfunction and may serve as non-invasive biomarkers for early CLI detection and treatment. The method improves ceramides (400 mL), phospholipid ratio (1.5), acylcarnitines (6 L), OxPLs (300 mL), index score (<0.4), and mediator levels (200 mL). The reduction denotes decreased ceramide concentration (µmol/mL or ng/mL), normalised to total lipid content in affected tissues. This measure reflects how ceramide alterations disrupt lipid homeostasis and mitochondrial function in critical limb ischaemia (CLI).
    Keywords:  Lipidomics; arteriosclerosis obliterans; biomarkers; critical limb ischaemia; mass spectrometry; mitochondrial dysfunction
    DOI:  https://doi.org/10.1080/13813455.2025.2592019
  21. J Alzheimers Dis. 2026 Mar 10. 13872877261424276
      Decline in mitochondrial quality is a prominent pathological feature of Alzheimer's disease (AD), manifested by impaired energy metabolism, disrupted mitochondrial biogenesis, abnormal mitochondrial dynamics, and defective mitophagy. Increasing evidence indicates that mitochondrial dysfunction contributes to the exacerbation of amyloid-β (Aβ) deposition and tau protein hyperphosphorylation, thereby accelerating AD pathogenesis. Of particular interest, physical exercise has been shown to effectively enhance mitochondrial quality and help prevent or slow the progression of AD, largely through the activation of key signaling pathways such as adenosine monophosphate-activated protein kinase (AMPK) and sirtuin 1 (SIRT1). However, regular physical activity may not be feasible for individuals in the prodromal or clinical stages of AD. In this context, exercise mimetics-compounds that pharmacologically simulate the molecular effects of exercise-have emerged as a promising alternative intervention. This review analyzes the mechanistic roles of exercise mimetics in improving mitochondrial quality under AD conditions, with a focus on their regulation of mitochondrial homeostasis via key signaling pathways. It further aims to provide theoretical insight for the development of mitochondria-targeted exercise mimetics and offer a potential strategy for addressing the growing global burden of AD.
    Keywords:  Alzheimer's disease; brain-derived neurotrophic factor; exercise mimetics; irisin; metformin; mitochondrion; resveratrol
    DOI:  https://doi.org/10.1177/13872877261424276
  22. J Photochem Photobiol B. 2026 Mar 04. pii: S1011-1344(26)00058-8. [Epub ahead of print]278 113411
       BACKGROUND: Chemotherapy-induced peripheral neuropathy (CIPN) is a common and serious side effect of paclitaxel-based chemotherapy, with limited therapeutic options that often prove ineffective. Photobiomodulation (PBM), a non-invasive therapeutic approach utilizing near-infrared light, has shown promise in fostering nerve regeneration and modulating inflammatory responses. This study aimed to assess both the therapeutic efficacy and the underlying molecular mechanisms of PBM in a preclinical model of CIPN.
    METHODS: The effects of 808 nm near-infrared PBM were evaluated in both in vivo and in vitro CIPN models. A murine CIPN model was developed and subjected to three weeks of continuous PBM treatment. Behavioral assessments, intraepidermal nerve fiber (IENF) density analysis, and mitochondrial ultrastructural evaluations were performed in the in vivo experiments. For in vitro investigations, N2a neuroblastoma cells and normal human astrocytes (NHA) were exposed to albumin-bound paclitaxel (nab-paclitaxel), with or without PBM therapy. Cellular assays were conducted to evaluate cell viability, inflammatory cytokine secretion, oxidative stress levels, mitochondrial functionality, and apoptosis.
    RESULTS: PBM significantly ameliorated mechanical and cold hypersensitivity in CIPN mice, restored IENF density, preserved mitochondrial ultrastructure, and reduced oxidative tissue damage. In addition, PBM enhanced neuronal cell proliferation, reduces the expression of pro-inflammatory cytokines, attenuated oxidative stress, stabilized mitochondrial membrane potential, increased ATP production, and inhibited paclitaxel-induced apoptosis through regulation of the mitochondrial pathway.
    CONCLUSIONS: Near-infrared PBM effectively mitigates CIPN by promoting neural repair, suppressing neuroinflammation and oxidative stress, and preserving mitochondrial function. These findings highlight PBM as a potential non-pharmacological therapeutic option for CIPN management and suggest that further clinical investigations are warranted.
    Keywords:  Albumin-bound paclitaxel; Chemotherapy-induced peripheral neuropathy; Mitochondrial dysfunction; Oxidative stress; Photobiomodulation
    DOI:  https://doi.org/10.1016/j.jphotobiol.2026.113411
  23. Int J Mol Sci. 2026 Feb 28. pii: 2267. [Epub ahead of print]27(5):
      In the last decades, ozone (O3)-based medical treatments have become a widely applied complementary therapy for several pathological conditions. O3 is administered at low dosages since the induction of a mild oxidative stress does not cause damage but stimulates the antioxidant cell response through the nuclear factor erythroid 2-related factor 2 (Nrf2). Mitochondria are sensitive to even mild oxidative stress, thus being a responsive target for O3. This study aimed to evaluate the mitochondrial response to low O3 doses used for medical treatments. As the skeletal muscle represents a primary target in local O3 treatments, a murine non-tumoral muscle cell line was selected as an appropriate in vitro model. Transmission electron microscopy, biochemistry, and flow cytometry provided original information on the O3 dose-dependent modifications of mitochondrial structural and molecular features. Low O3 doses promoted an increase in mitochondrial area and in cristae extension, as well as an enhancement of the electron transport chain complexes and of antioxidant catalase and manganese-dependent superoxide dismutase. Nrf2 maintained its association with the outer mitochondrial membrane, thus exerting its protective role. All mitochondrial modifications were observed 24 h after treatment and disappeared after 48 h, demonstrating that cells promptly respond to the O3-driven oxidative stress, effectively restoring homeostasis.
    Keywords:  medical ozone; mitochondrial cristae; mitochondrial respiratory chain complexes; mitochondrial size; nuclear factor erythroid 2-related factor 2 (Nrf2); reactive oxygen species; transmission electron microscopy
    DOI:  https://doi.org/10.3390/ijms27052267
  24. Mol Neurobiol. 2026 Mar 11. pii: 493. [Epub ahead of print]63(1):
      Alzheimer's disease (AD) is a progressive neurodegenerative disorder marked by memory loss and cognitive decline, predominantly in the elderly (Alzheimer Disease International et al., 2015). Although amyloid-β peptide (Aβ), particularly in its oligomeric forms, has long been linked to AD pathogenesis (Chen 9:1205-1235 2017, Gaspar 2 394-400 2010), the mechanisms underlying its cellular toxicity remain unclear. Mitochondrial dysfunction is a consistent feature of AD (D'Alessandro 107:102713 2025), yet how Aβ drives these alterations is not fully understood. This review integrates recent evidence showing that Aβ accumulates on mitochondrial membranes (Cenini 21:3257-3272 2016, Manczak 23:5131-5146 2006, Sirk 5:1989-2003 2007), providing a mechanistic link between amyloid pathology and mitochondrial damage. We discuss how membrane-associated Aβ disrupts mitochondrial protein import by impairing the translocase of the outer membrane (TOM) complex (Cenini 21:3257-3272 2016, Sirk 5:1989-2003 2007) and interferes with voltage-dependent anion channel 1 (VDAC1) (Smilansky 52:30670-30683 2015), a key regulator of metabolite exchange and apoptosis. We further emphasize the role of mitochondria-associated membranes (MAMs) as critical sites for Aβ generation and transfer to mitochondria, where dysregulated cholesterol metabolism may amplify MAM activity and Aβ accumulation (Area-Gomez and Schon 38:90-96 2017, Monaghan 2:240287 2025). Altogether, we propose that mitochondrial membrane localization of Aβ is a central mechanism linking amyloid pathology to mitochondrial dysfunction in aging, highlighting new directions for mitochondria-targeted therapeutic strategies in AD.
    Keywords:  Amyloid-β; Cholesterol; Mitochondria; Mitochondria-associated membranes; Proteostasis; Translocase of outer membrane; Voltage-dependent anion channel
    DOI:  https://doi.org/10.1007/s12035-026-05786-z
  25. Free Radic Biol Med. 2026 Mar 11. pii: S0891-5849(26)00225-X. [Epub ahead of print]
      Mitochondrial stress (MS) is a hallmark of a number of aging-associated neurodegenerative diseases, including Parkinson's disease (PD). Chronic MS in PD disrupts neuronal proteostasis, causing dopaminergic neurodegeneration through inactivation of an E3 ubiquitin ligase, parkin, although the mechanism of its inactivation is not understood. Here, we elucidate a mechanistic framework linking progressive changes in mitochondrial mass with MS-induced alterations in parkin activity. We showed that acute and chronic MS differentially modulate parkin activity and regulate mitochondrial biogenesis by transcriptional control of peroxisome proliferator-activated receptor γ coactivator 1α (PGC1α), through parkin substrate PARIS (parkin-interacting substrate). Acute exposure to the PD neurotoxin, 1-methyl-4-phenylpyridinium (MPP+), activates the parkin-PARIS-PGC1α pathway, transiently facilitating mitochondrial biogenesis. However, sustained and repetitive MS leads to parkin mis localization, inactivation, and aggregation, resulting in PARIS accumulation, repression of PGC1α activity, and loss of mitochondrial mass. Nuclear Factor Erythroid 2-related Factor 2 (NFE2L2 or NRF2) activation by methylene blue (MB) transcriptionally upregulates parkin expression by enhancing its binding to NRF2/ antioxidant responsive element (ARE) within the PARK2 promoter. MB treatment in cells exposed to chronic MPP+ reduces PARIS levels, restores PGC1α activity, and rejuvenates mitochondria. These findings underscore the impact of chronic mitochondrial damage on parkin dysfunction in PD and suggest a promising role for MB in protecting against mitochondrial and proteostatic failure in PD by targeting the NRF2-parkin axis.
    Keywords:  E3 ubiquitin ligase; dopaminergic neurodegeneration; mitochondria; parkin; proteostasis
    DOI:  https://doi.org/10.1016/j.freeradbiomed.2026.03.034
  26. Nature. 2026 Mar 11.
      Lung cancer predominantly affects older individuals, yet how physiological ageing influences tumour evolution remains poorly understood1. Here we show that ageing reprograms the evolutionary trajectory of KRAS-driven lung adenocarcinoma, limiting primary tumour growth while promoting metastatic dissemination through epigenetic activation of the integrated stress response (ISR). The ISR effector ATF4 drives epithelial and metabolic plasticity, conferring metastatic competence. Mechanistically, aged tumour cells show increased sensitivity to the PERK-eIF2α arm of the unfolded protein response, sustaining persistent ATF4 signalling. Targeting ISR-ATF4 genetically or pharmacologically abolishes these adaptations and limits dissemination, whereas ATF4 overexpression alone is sufficient to induce metastasis. The ageing-ATF4 axis imposes a dependency on glutamine metabolism, revealing a therapeutically actionable vulnerability. Clinical analyses confirm that ATF4 is enriched in aged tumours and correlates with poor survival and advanced-stage disease. Collectively, these results define epigenetic ISR-ATF4 activation as a causal driver of lineage plasticity and metastasis in aged tumours, revealing a therapeutic opportunity in older patients with lung adenocarcinoma, the most common yet understudied subset of lung cancer.
    DOI:  https://doi.org/10.1038/s41586-026-10216-0
  27. Int J Med Sci. 2026 ;23(3): 1144-1160
      Hundreds of millions of people worldwide endure continuous suffering and significant economic burdens due to inflammatory diseases. Various acute and chronic inflammatory diseases and the natural aging of the human body are common causes of organ damage. Therefore, how to reasonably regulate inflammation, tissue repair and regeneration after organ damage has been of great concern, especially the pathological repair caused by inflammation will lead to the destruction of the original structure and function of tissues and organs. Low-intensity pulsed ultrasound (LIPUS) is a promising non-invasive physical therapy that can produce different biological effects on organs, tissues and cells. Certain clinical trials have demonstrated the outstanding capacity of LIPUS in anti-inflammation and repair. Many in vivo and in vitro basic studies have also reported the molecular effect mechanisms by which LIPUS exerts capacity of anti-inflammation and repair. This review focuses on the molecular mechanism of LIPUS anti-inflammation and repair and emphasizes the crucial role of LIPUS in various diseases. In addition, we compile clinical trials to provide readers with a more thorough understanding of the current potential of LIPUS in inflammation control and organ function restoration.
    Keywords:  inflammation; low-intensity pulsed ultrasound (LIPUS); molecular mechanism; repair; signaling pathway
    DOI:  https://doi.org/10.7150/ijms.124996
  28. Trends Mol Med. 2026 Mar 12. pii: S1471-4914(26)00013-4. [Epub ahead of print]
      A recent study by Angelino et al. uncovered an intracellular signaling pathway involved in musculoskeletal mitochondrial dysfunction in cancer cachexia. Both humans and mice with cancer cachexia display impaired 3',5'-cyclic adenosine monophosphate (cAMP)-protein kinase A-cAMP response element-binding protein 1 signaling, which leads to mitochondrial dysfunction. By rescuing this pathway with a phosphodiesterase-4 inhibitor, the authors highlight a potential therapeutic strategy for cancer cachexia.
    Keywords:  PDE4D; cAMP; cancer cachexia; mitochondrial dysfunction
    DOI:  https://doi.org/10.1016/j.molmed.2026.01.009
  29. Hum Cell. 2026 Mar 10. pii: 52. [Epub ahead of print]39(3):
      Mesenchymal stromal cells (MSCs) hold significant promise in regenerative medicine, yet their clinical application is hindered by challenges such as cellular heterogeneity and quality control. This study aims to develop a rapid, noninvasive method for evaluating the quality of MSCs using femtosecond laser label-free imaging (FLI). We examined the proliferation, metabolic dynamics, and differentiation potential of MSCs from various tissue sources, including human dental pulp, umbilical cord, and fat, across different passages. Conventional experiments show that as the number of passages increases, the morphology of MSCs alters, proliferation capacity decreases, β-galactosidase activity linked to aging rises, and both osteogenic and adipogenic differentiation abilities markedly decline. FLI technology effectively captures these changes: reduced NAD(P)H/FAD ratio in higher-passage cells suggests decreased metabolic activity, while enhanced aging-related fluorescence signals, such as lipofuscin, align with cellular senescence. In the assessment of differentiation capability, increased fluorescence intensity of NAD(P)H and FAD signals indicates heightened metabolic activity within the cells. With the passages increasing, the fluorescence intensities of NAD(P)H and FAD decline, suggesting diminished ability of cell differentiation. Furthermore, during osteogenic differentiation, the optical REDOX ratio (FAD/(NAD(P)H + FAD)) decreases with successive passages, whereas during adipogenic differentiation, it increases. Three-dimensional FLI of suspension cells further reveals that the cells of lower-passage exhibit greater spatial heterogeneity in metabolic signals, possibly reflecting more active mitochondrial function. This study demonstrates that FLI technology can effectively assess the proliferation activity, senescence, and differentiation potential of MSCs through noninvasive, dynamic monitoring of their metabolic status and morphological features, offering a novel approach for standardized quality assessment of MSCs preparations.
    Keywords:  FLI; MSCs; Metabolism; Quality control
    DOI:  https://doi.org/10.1007/s13577-026-01366-4
  30. Trends Pharmacol Sci. 2026 Mar 12. pii: S0165-6147(26)00040-4. [Epub ahead of print]
      Idiopathic pulmonary fibrosis (IPF) is a progressive, age-associated interstitial lung disease with limited therapeutic options. Current antifibrotics modestly slow the decline but fail to halt or reverse fibrosis. Emerging evidence implicates two central hallmarks of aging-cellular senescence and impaired autophagy-in IPF pathogenesis. Senescent epithelial and stromal cells secrete proinflammatory and profibrotic mediators, while defective autophagic flux exacerbates protein and organelle accumulation, mitochondrial dysfunction, and maladaptive stress responses. Increasingly, these processes are recognized as reciprocally regulated, converging on signaling pathways such as transforming growth factor-β, adenosine monophosphate-activated protein kinase/mechanistic target of rapamycin, nuclear factor kappa-light-chain enhancer of activated B cells, and reactive oxygen species. This review examines the senescence-autophagy axis, outlines conceptual frameworks to reconcile its paradoxical functions, and highlights emerging therapeutic strategies, including drug repurposing and next-generation interventions.
    Keywords:  autophagic flux; idiopathic pulmonary fibrosis; senescence; senescence–autophagy crosstalk; therapeutic targets
    DOI:  https://doi.org/10.1016/j.tips.2026.02.007
  31. J Inflamm Res. 2026 ;19 577143
      Sepsis is a life-threatening syndrome characterized by infection-induced systemic inflammation and immune dysregulation, commonly resulting in the development of multiple organ dysfunction syndrome (MODS), a leading cause of mortality in clinical practice. In decades, immunometabolic reprogramming has been identified as a critical mechanism that contributes to the progression of sepsis and the associated organ injuries. The review provides a systematic overview of the metabolic alterations in immune cells and organs in experimental models of sepsis. Key features include enhanced glycolysis, impaired mitochondrial function, and disturbed lipid metabolism, all of which are closely associated with organ damage. These metabolic adaptations influence immune responses and cell fate decisions, inter-organ crosstalk, and the development of MODS. A detailed examination is conducted on the temporal progression of pathological changes in established animal models, along with organ-specific metabolic dysfunctions and novel therapeutic targets. It emphasizes the importance of dynamic immunometabolic regulation, tissue-specific responses, and inter-organ interactions in the context of sepsis treatment. The integration of multi-omics technologies, identification of reliable biomarkers, and the development of personalized therapeutic strategies should be used to facilitate clinical translation of mechanistic insights.
    Keywords:  experimental sepsis; glycolysis; immunometabolic reprogramming; inter-organ crosstalk; multiple organ dysfunction syndrome
    DOI:  https://doi.org/10.2147/JIR.S577143
  32. Mol Biomed. 2026 Mar 13. pii: 30. [Epub ahead of print]7(1):
      The traditional view of reactive oxygen species (ROS) as uniform toxicants has been superseded by the recognition of a fundamental radical/non-radical dichotomy. As radical and non-radical ROS differ in spatial and kinetic behaviors that dictate cellular impacts, understanding this dichotomy is essential for the design of ROS-targeting therapies. However, the roles of specific ROS types under physiological and pathological conditions remain inadequately defined, hindering precise clinical translation. By organizing ROS sources, neutralizing systems, reaction kinetics, biological effects, and therapeutic strategies along a radical versus non-radical axis, this review clarifies their unique and shared attributes to facilitate effective exploitation for health and disease management. Radical species, being short-lived and membrane-confined, operate locally at near-diffusion-limited rates, whereas non-radical species support compartment-transcending redox communication. Both types mediate beneficial eustress at low physiological levels, suitable for health promotion; yet provoke oxidative distress at high concentrations, forming the basis for numerous therapeutic applications. We examine how this radical versus non-radical dichotomy guides contemporary redox interventions. In health, while low-dose radicals enhance stress resilience and metabolic adaptation, non-radicals regulate physiological plasticity; in disease, radical-focused therapies enable precise cytotoxicity, and non-radical approaches permit spatially programmable signaling. Furthermore, we highlight the promise of hybrid ROS-targeting strategies leveraging their capacity for synchronized and tunable delivery of both radical and non-radical species, enabling broad therapeutic potential. By delineating ROS biology along chemical and spatial principles, this framework advances targeted redox interventions for complex diseases, underscoring the indispensable role of radical processes in oncology.
    Keywords:  Cancer; Cold atmospheric plasma; Non-radical; Plasma complex medicine; Radical; Reactive oxygen species
    DOI:  https://doi.org/10.1186/s43556-026-00419-2
  33. Cells. 2026 Mar 06. pii: 475. [Epub ahead of print]15(5):
      Type 2 diabetes (T2D) is a pressing global health challenge, primarily driven by modern dietary and lifestyle patterns. Central to T2D progression is the dysfunction of insulin-secreting pancreatic β-cells, which critically disrupts glucose homeostasis. The progression to T2D relies on the β-cells' inability to compensate for increasing insulin resistance. Initially, β-cells enhance the insulin output, but chronic nutrient overload, ER stress and inflammation ultimately compromise their function and survival. This review examines the molecular and cellular drivers of β-cell failure, focusing on endoplasmic reticulum stress, mitochondrial dysfunction and inflammatory pathways amid chronic metabolic stress. We also explore the loss of β-cell identity and altered interactions within the islet microenvironment. Understanding these mechanisms is essential for developing strategies to prevent β-cell dysfunction and slow T2D progression, ultimately supporting better metabolic health outcomes.
    Keywords:  ER stress; UPR; dedifferentiation; insulin; metabolic stress; obesity; pancreatic β-cells; type 2 diabetes
    DOI:  https://doi.org/10.3390/cells15050475